SCHEMBL2992722

SCHEMBL2992722

c1[nH]nnc1N1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
HPGD P15428 3/20 0.38
CASP1 P29466 1/20 0.37
CASP4 P49662 1/20 0.37
CASP5 P51878 1/20 0.37
HRH4 Q9H3N8 1/20 0.36
CHRM3 P20309 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CRHBP P24387 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19839765 1.00 CYP1A2 (0.42) CYP1A2HPGDCASP1CASP4CASP5
Hydrochloric Acid SCHEMBL28005032 0.98 CYP1A2 (0.41) CYP1A2HPGDCASP1CASP4CASP5
SCHEMBL935607 0.98 CYP1A2 (0.39) CYP1A2HPGDCASP1CASP4CASP5
Hydrochloric Acid SCHEMBL9551436 0.96 CYP1A2 (0.38) CYP1A2HPGDCASP1CASP4CASP5
SCHEMBL1013538 0.93
SCHEMBL17610176 0.89
SCHEMBL4465183 0.81 BPTF (0.47) CYP1A2HPGDCASP1CASP4CASP5
Hydrochloric Acid SCHEMBL28019382 0.79 BPTF (0.46) CYP1A2HPGDCASP1CASP4CASP5
SCHEMBL5830533 0.79 CNR2 (0.32) CYP1A2SMN1; SMN2ALDH1A1KDM4EGAA
SCHEMBL2821690 0.79 CYP2C19 (0.41) CYP1A2SMN1; SMN2ALDH1A1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260090510-A1 USE OF RESIN ACIDS AS DEFENSE GENE INDUCERS FOR BIOTIC STRESS IN PLANTS ACTION PIN (FR) 2026-04-02 US claimed
EP-4593595-A1 USE OF RESIN ACIDS AS DEFENSE GENE INDUCERS FOR BIOTIC STRESS IN PLANTS ACTION PIN (FR) 2025-08-06 EP claimed
WO-2024068671-A1 USE OF RESIN ACIDS AS DEFENSE GENE INDUCERS FOR BIOTIC STRESS IN PLANTS ACTION PIN (FR) 2024-04-04 WO claimed
EP-2614823-A1 Use of triazolylpiperidine derivatives Bergen Teknologioverføring AS (NO) 2013-07-17 EP claimed
EP-2465848-A1 Triazolylpiperidine derivatives and method for making the same Bergen Teknologioverføring AS (NO) 2012-06-20 EP claimed
US-20120149908-A1 TRIAZOLYLPIPERIDINE DERIVATIVES AND METHOD FOR MAKING THE SAME BERGEN TEKNOLOGIOVERFOERING AS (NO) 2012-06-14 US claimed
US-6858667-B1 Releasable adhesive for attachments of substrates and joints HELLA KG HUECK & CO. (DE) 2005-02-22 US claimed
US-20260109708-A1 COMPOUNDS AND COMPOSITIONS USEFUL AS DEGRADERS OF MK2 KINASE CELGENE CORP (US) 2026-04-23 US disclosed
US-12599600-B2 Compositions and methods for preventing and treating headache through enhancing 2-arachydonyl glyerol activity ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2026-04-14 US disclosed
US-20260090510-A1 USE OF RESIN ACIDS AS DEFENSE GENE INDUCERS FOR BIOTIC STRESS IN PLANTS ACTION PIN (FR) 2026-04-02 US disclosed
EP-4661875-A1 COMPOUNDS AND COMPOSITIONS USEFUL AS DEGRADERS OF MK2 KINASE Celgene Corporation (US) 2025-12-17 EP disclosed
EP-4593595-A1 USE OF RESIN ACIDS AS DEFENSE GENE INDUCERS FOR BIOTIC STRESS IN PLANTS ACTION PIN (FR) 2025-08-06 EP disclosed
US-12187687-B2 Compositions and uses thereof UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2025-01-07 US disclosed
US-20100173895-A1 IMIDAZOLOPYRIMIDINES AND IMIDAZOLOTRIAZINE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE(PARP) INSTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI (IT) 2010-07-08 US disclosed
US-20090209523-A1 Pyrrolo[1,2-A] Pyrazin-1(2H)-One and Pyrrolo[1,2-D][1,2,4]Triazin-1(2H)-One Derivatives as Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-08-20 US disclosed
CN-101445488-A Triazoles compounds with antimicrobial activity and preparation method and pharmaceutical use thereof UNIV SOUTHWEST (CN) 2009-06-03 CN disclosed
EP-2032140-A1 PYRROLO[1,2-A]PYRAZIN-1(2H)-ONE AND PYRROLO[1,2-D][1,2,4]TRIAZIN-1(2H)-ONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE(PARP) Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2009-03-11 EP disclosed
WO-2007138355-A1 PYRROLO[1,2-A]PYRAZIN-1(2H)-ONE AND PYRROLO[1,2-D][1,2,4]TRIAZIN-1(2H)-ONE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE(PARP) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-12-06 WO disclosed
US-20070093659-A1 Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-04-26 US disclosed
US-4481360-A 4H-1,2,4-Triazol-3-yl compounds THE UPJOHN COMPANY (US) 1984-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12599600-B2 Compositions and methods for preventing and treating headache through enhancing 2-arachydonyl glyerol activity FAAH2, PTGS2, PTGES2 CYP1A2 669/4885HPGD 71/4885CASP1 3590/4885
US-20120149908-A1 TRIAZOLYLPIPERIDINE DERIVATIVES AND METHOD FOR MAKING THE SAME AZI2, AOC3, ALKBH3 CYP1A2 18/4885HPGD 230/4885CASP1 4275/4885
US-20260090510-A1 USE OF RESIN ACIDS AS DEFENSE GENE INDUCERS FOR BIOTIC STRESS IN PLANTS CD68, GRIA3, GRIA1 CYP1A2 1652/4885HPGD 3469/4885CASP1 4295/4885
US-20070093659-A1 Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication NQO2, NOX1, NOX3 CYP1A2 951/4885HPGD 2290/4885CASP1 1309/4885
US-12187687-B2 Compositions and uses thereof CYP11B2, CYP11B1, NQO1 CYP1A2 32/4885HPGD 788/4885CASP1 1391/4885
US-20100173895-A1 IMIDAZOLOPYRIMIDINES AND IMIDAZOLOTRIAZINE DERIVATIVES AS INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE(PARP) PARP1, PARP2, PARP15 CYP1A2 2136/4885HPGD 1192/4885CASP1 183/4885
US-20260109708-A1 COMPOUNDS AND COMPOSITIONS USEFUL AS DEGRADERS OF MK2 KINASE PSME2, MKRN3, RPS6KA2 CYP1A2 1612/4885HPGD 3118/4885CASP1 4562/4885
US-20090209523-A1 Pyrrolo[1,2-A] Pyrazin-1(2H)-One and Pyrrolo[1,2-D][1,2,4]Triazin-1(2H)-One Derivatives as Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) PARP1, PARP2, PARP11 CYP1A2 2141/4885HPGD 957/4885CASP1 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.